Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

biochp

  • Home
  •  
  • biochp



  • Most Read
  • Latest Comments
  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Archer Materials delivers breakthrough proof-of-concept devices for quantum computing chip production
    Archer Materials delivers breakthrough proof-of-concept devices for quantum computing chip production
    • News

  • Archer begins new experiments for its lab-on-a-chip for kidney disease detection
    Archer begins new experiments for its lab-on-a-chip for kidney disease detection
    • News

  • Archer Materials advances Biochip technology with new design for manufacturing to be tested in Finland
    Archer Materials advances Biochip technology with new design for manufacturing to be tested in Finland
    • News

  • Nuheara collapses after failing to renegotiate debt obligations
    Nuheara collapses after failing to renegotiate debt obligations
    • News

  • Archer unveils breakthrough testing method for graphene transistors to identify optimal stability and accuracy
    Archer unveils breakthrough testing method for graphene transistors to identify optimal stability and accuracy
    • News

  • Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing
    • News

    Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing

    Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the next generation of medical diagnostics through the successful manufacture of its graphene ‘lab-on-a-chip’ biochip in a commercial semiconductor foundry. Scaling the design and production of graphene chips to be used as biological sensors is a significant challenge to commercialising what could potentially

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.